Orthovita Inc. (VITA) is Making Bones about It
Orthovita Inc. is a NASDAQ-traded spine and orthopedic biosurgery company. They are a premier developer of biomaterial product platforms for bone regeneration and soft tissue healing. Headquartered in Malvern, Pennsylvania, the company also has a European headquarters in Leuven, Belgium. They are part of the Medical Instruments and Supplies industry and have a market capitalization of $220.09 million. Orthovita has four main product lines. Their VITOSS® Bone Graft Substitute technology platform is a synthetic bone graft substitute for the repair of bony defects in the spine, extremities, and the pelvis. An osteoconductive porous implant, it resembles the multidirectional interconnected porosity…